As of May 26
| +0.06 / +1.45%|
The 7 analysts offering 12-month price forecasts for Achillion Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 13.00 and a low estimate of 5.00. The median estimate represents a +42.52% increase from the last price of 4.21.
The current consensus among 7 polled investment analysts is to Buy stock in Achillion Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.